Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges

著者: Annenberg Center for Health Sciences
  • サマリー

  • An indolent subtype of non-Hodgkin lymphoma, follicular lymphoma is characterized by eventual relapse of disease and the need for multiple lines of therapy, adding to the significant disease burden experienced by patients. Novel targeted agents in the relapsed/refractory setting have afforded new treatment options, but important clinical challenges exist, including optimal treatment sequencing, therapy evaluation and patient selection, transitions of care requirements, as well as toxicity management.
    Annenberg Center for Health Sciences
    続きを読む 一部表示

あらすじ・解説

An indolent subtype of non-Hodgkin lymphoma, follicular lymphoma is characterized by eventual relapse of disease and the need for multiple lines of therapy, adding to the significant disease burden experienced by patients. Novel targeted agents in the relapsed/refractory setting have afforded new treatment options, but important clinical challenges exist, including optimal treatment sequencing, therapy evaluation and patient selection, transitions of care requirements, as well as toxicity management.
Annenberg Center for Health Sciences
エピソード
  • Solving Practice Challenges in Community-Based Interprofessional Care Teams
    2023/12/14

    In this 1-hour, online activity, lymphoma expert Jeremy Abramson, MD, shares his experience navigating these challenges as part of an interprofessional, multidisciplinary care team.

    続きを読む 一部表示
    50 分

Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challengesに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。